Skip to main content
SP5007,752.39-0.43%DOW53,500.30-0.43%NASDAQ26,649.33-0.30%BTC$64,308.00+1.87%ETH$1,906.40+1.14%GOLD$4,459.30+0.50%OIL$84.39+2.42%
Smart Investors Daily
Sign InSign Up Free
CO

NASDAQ · COCHW

Envoy Medical, Inc.

Healthcare · Medical - Devices

$0.03

Up+$0.01 (+37.87%)

Updated Aug 17, 2026, 7:15 PM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
777.92K
P/E ratio
-0.75
Dividend yield
0.00%
52-week range
$0.02 – $0.10
Volume
543
Avg. volume
38.74K

Price performance

COCHW price history

1M range · 12 trading sessions · Daily adjusted prices

COCHW closed at $0.03 after 12 trading sessions, down 3.83% for the selected period.

Last close
$0.03
Period change
-3.83%
Period low
$0.03
Period high
$0.05
Daily close
View OHLC price history
COCHW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 12, 2026$0.0301$0.0301$0.0301$0.0301543
Aug 11, 2026$0.05$0.05$0.05$0.0524.95K
Aug 7, 2026$0.0405$0.0405$0.0405$0.0405363
Aug 4, 2026$0.0389$0.0499$0.0388$0.045654.41K
Aug 3, 2026$0.0375$0.0375$0.034$0.034633
Jul 31, 2026$0.03$0.0321$0.03$0.0315.03K
Jul 30, 2026$0.0385$0.0385$0.036$0.03612.09K
Jul 29, 2026$0.0331$0.0331$0.0265$0.0265251
Jul 28, 2026$0.0382$0.0382$0.0328$0.03281.32K
Jul 27, 2026$0.038$0.0398$0.038$0.03811.42K
Jul 24, 2026$0.0378$0.0378$0.0378$0.0378281
Jul 23, 2026$0.05$0.05$0.0313$0.03131.44K

Latest COCHW news

The latest Smart Investors Daily articles mentioning COCHW.

Stock researchCompany · Overview

COCHW research

Overview

Company profile and research snapshot.

Company profile

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jun 25, 2026

Envoy Medical Terminates At-the-Market (ATM) Equity Facility

Termination Reflects Company's Confidence in Current Capital PositionWhite Bear Lake, Minnesota--(Newsfile Corp. - June 25, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has formally terminated its at-the-market equity facility (the "ATM Facility").The ATM Facility, under which the Company was previously authorized to offer and sell up to $15 million worth of shares of its common stock

Yahoo · Feb 24, 2026

Envoy Medical Regains Compliance with Nasdaq Listing Requirement

White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(2) through the alternatives permitted under Listing Rule 5550(b).As previously disclosed, the Company..

Yahoo · Feb 23, 2026

Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space

White Bear Lake, Minnesota--(Newsfile Corp. - February 23, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the issuance of three new patents with one in the United States and two in Hong Kong, further expanding its intellectual property and reinforcing its competitive position in the cochlear implant industry."We believe the future of the cochlear implant industry is fully...

Yahoo · Feb 19, 2026

Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial

Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor Closing of $30 million in gross proceeds in upsized offering, with up to an additional $48 Million upon exercise of milestone warrants, provides potential funding through commercialization Company hosting Fireside Chat with Dr. Theodore McRackan, on February 25th at 10 a.m. ET, to discuss his initial experiences as clinical trial's leading...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By